Oncopharmpod
Lessons Learned (from the last week)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:23:46
- More information
Informações:
Synopsis
Providing some clinical pearls learned in the last week regarding patient education for ruxolitinib & alectinib. Then (11:50) we recap follow-up publications from Keynote-24 & the BRIGHT studies, before finishing up the week's journal scan with a discussion of the optimal dose of nivolumab + ipilimumab in melanoma and who may NOT benefit from palbociclib.